Jyong Biotech Ltd. Ordinary Shares [NASDAQ: MENS]

Jyong Biotech Ltd.

INDUSTRY: BIOTECHNOLOGY

Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages more

Market Data & Performance

Current Price ($):$7.99

Previous Close ($):$0.00

Open Price ($):$15.00

Day High ($):$19.99

Day Low ($):$7.63

Market Cap ($mm):$0M

52 Week Range:7.63-19.9

IPO Details

Offer Price ($):$7.50

IPO Date / IPO File Date:06/17/2025

Trade Date:06/17/2025

Offer Shares (mm):2.7M

Underwriters:Joseph Stone Capital

Company Profile

Outstanding Shares (mm):0.0M

Headquarters:New Taipei City, TW

Employees at IPO:31

Exchange:NASDAQ

Jyong Biotech Ltd. Ordinary Shares [MENS] Performance

Jyong Biotech Ltd. Ordinary Shares [NASDAQ: MENS]

Recently Viewed